• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    FAT1, a direct transcriptional target of E2F1, suppresses cell proliferation, migration and invasion in esophageal squamous cell carcinoma

    2019-09-10 09:41:56YuWangGuangchaoWangYunpingMaJingleiTengYanWangYongpingCuiYanDongShujuanShaoQiminZhanXuefengLiu
    Chinese Journal of Cancer Research 2019年4期

    Yu Wang, Guangchao Wang, Yunping Ma, Jinglei Teng, Yan Wang, Yongping Cui, Yan Dong,Shujuan Shao, Qimin Zhan,, Xuefeng Liu

    1Institute of Cancer Stem Cell, Dalian Medical University, Dalian 116044, China; 2State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021, China; 3Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Laboratory of Molecular Oncology, Peking University Cancer Hospital & Institute, Beijing 100142, China; 4Shenzhen Peking University-The Hong Kong University of Science and Technology (PKU-HKUST) Medical Center, Peking University Shenzhen Hospital, Shenzhen 518036, China; 5College of Stomatology, Dalian Medical University, Dalian 116044, China; 6Key Laboratory of Proteomics, Dalian Medical University, Dalian 116044, China Correspondence to: Xuefeng Liu. Institute of Cancer Stem Cell, Dalian Medical University, Dalian 116044, China. Email: ixuee@sina.com; Qimin Zhan. Institute of Cancer Stem Cell, Dalian Medical University, Dalian 116044, China; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Laboratory of Molecular Oncology, Peking University Cancer Hospital &Institute, Beijing 100142,China. Email: zhanqimin@bjmu.edu.cn.

    Abstract Objective: Growing evidence indicates that FAT atypical cadherin 1 (FAT1) has aberrant genetic alterations and exhibits potential tumor suppressive function in esophageal squamous cell carcinoma (ESCC). However, the role of FAT1 in ESCC tumorigenesis remains not well elucidated. The aim of this study was to further investigate genetic alterations and biological functions of FAT1, as well as to explore its transcriptional regulation and downstream targets in ESCC.Methods: The mutations of FAT1 in ESCC were achieved by analyzing a combined study from seven published genomic data, while the copy number variants of FAT1 were obtained from an analysis of our previous data as well as of The Cancer Genome Atlas (TCGA) and Cancer Cell Line Encyclopedia (CCLE) databases using the cBioPortal. The transcriptional regulation of FAT1 expression was investigated by chromatin immunoprecipitation(ChIP) and the luciferase reporter assays. In-cell western, Western blot and reverse transcription-quantitative polymerase chain reaction (RT-qPCR) were used to assess the indicated gene expression. In addition, colony formation and Transwell migration/invasion assays were employed to test cell proliferation, migration and invasion.Finally, RNA sequencing was used to study the transcriptomes.Results: FAT1 was frequently mutated in ESCC and was deleted in multiple cancers. Furthermore, the transcription factor E2F1 occupied the promoter region of FAT1, and depletion of E2F1 led to a decrease in transcription activity and mRNA levels of FAT1. Moreover, we found that knockdown of FAT1 promoted KYSE30 and KYSE150 cell proliferation, migration and invasion; while overexpression of FAT1 inhibited KYSE30 and KYSE410 cell proliferation, migration and invasion. In addition, knockdown of FAT1 led to enrichment of the mitogen-activated protein kinase (MAPK) signaling pathway and cell adhesion process.Conclusions: Our data provided evidence for the tumor suppressive function of FAT1 in ESCC cells and elucidated the transcriptional regulation of FAT1 by E2F1, which may facilitate the understanding of molecular mechanisms of the progression of ESCC.

    Keywords: E2F1; ESCC; FAT1; tumor suppressor

    Introduction

    Worldwide, esophageal cancer is one of the most aggressive tumors, and is highly prevalent in China (1,2). It is the 4th leading cause of cancer-related mortality in China, where esophageal squamous cell carcinoma (ESCC)is the major histological type (3,4). There are advances in the early detection and treatment of patients with ESCC,but the 5-year survival of global ESCC patients is still very poor (5,6). Several large-scale analyses demonstrated that some genes and pathways, such as TP53, RB1, CDKN2A,PIK3CA, Notch and FAT atypical cadherin 1 (FAT1), may contribute to ESCC tumorigenesis (7-11). Among these aberrant genes, the “sleeping giant” (12) FAT1 is inactivated by a two-hit model in ESCC tumors, where somatic mutations are often accompanied by the loss of heterozygosity or homozygous deletion (9,11), showing an anti-tumor activity (9,13,14). FAT1 encodes a cadherin-like trans-membrane protein and regulates the cell-cell contact,polarization, migration and growth of mammalian cells (15-17). Interestingly, FAT1 may function as both a tumor suppressor and an oncogene depending on different cell context (18-21). The inactivation of FAT1 via somatic mutations or deletions is also observed in multiple human cancers to promote Wnt/β-catenin signaling and tumorigenesis (18). Other mechanisms regulating FAT1 expression remain poorly understood and need further investigation.

    Transcriptional regulation by transcription factors is a critical way to affect gene expression. E2Fs are a large family of transcription factors that modulate gene expression by acting as either activators or repressors of transcription based on their structures and functions(22,23). In Homo sapiens, E2F transcription factor 1(E2F1), which is the first member of the E2F family, is characterized as an activating transcription factor to mediate various biological processes, including cell cycle progression, apoptosis, DNA-damage response and metastasis (24-27). E2F1 binds to promoters of target genes, such as G1/S regulated genes and apoptosis-related genes, to regulate their expression (28-30), predominantly by interacting with the RB pocket protein (31). Advances in high-throughput technologies reveal that E2F1 also occupies a large fraction of gene promoters (32), suggesting that it has a wide spread regulation role in the human genome. However, the transcriptional regulation of E2F1 on the FAT1 locus remains unknown.

    In this study, we comprehensively analyzed the genetic alterations of FAT1 in ESCC, as well as its copy number variants (CNVs) in other cancers. More importantly, the transcriptional regulation of FAT1 by E2F1 was elaborated.In addition, the effects of FAT1 on cell proliferation,migration and invasion were also monitored in ESCC cells.Finally, RNA sequencing (RNA-seq) was performed to investigate the gene expression profile upon FAT1 knockdown.

    Materials and methods

    Cell lines

    ESCC cell lines, KYSE30, KYSE150 and KYSE410, were generous gifts from Prof. Y Shimada of Kyoto University,Japan. All cell lines were cultured at 37 °C with 5% CO2in RPMI 1640 medium (Gibco) with 10% fetal bovine serum(FBS).

    Cell transfection

    Cells at the logarithmic growth phase were transfected with siRNAs or plasmids using Lipofectamine 2000 (Invitrogen,USA) according to the manufacturer's instructions. All siRNAs (25-mer duplex Stealth siRNAs) were obtained from Invitrogen, and the sequence information is as follows: siFAT1: HSS103568 and HSS176716 and siE2F1:HSS103016 and HSS103017. The FAT1-Trunc plasmid,which contains all key functional domains of FAT1 (18),was a generous gift from Dr. Luc GT Morris (Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center).

    Chromatin immunoprecipitation (ChIP)

    Pierce Magnetic ChIP Kit (Thermo Fisher, Waltham,USA) was used according to the manufacturer's instructions. Briefly, KYSE30 cells were cross-linked with formaldehyde and the nucleus was isolated. Chromatin DNA was fragmented and incubated with E2F1 antibody(ab179445; Abcam, Cambridge, UK) followed by addition of magnetic beads. After washing and purification, the precipitated chromatins were analyzed by quantitative polymerase chain reaction (qPCR). The primers targeting the FAT1 promoter were synthesized by Invitrogen, and the sequences are as follows: forward 5'-GGAGCTCACCC GCCGTCTCA-3' and reverse 5'-GCTCGTGCGGC AGGTACCA-3'.

    Luciferase reporter assay

    To obtain the pGL3-FAT1 vector, the promoter region of FAT1, ranging from -2000 bp to +500 bp, was synthesized and inserted into the pGL3-Basic vector by Generay(Shanghai, China). Then, KYSE30 cells were cotransfected by pGL3-FAT1 vector and pRL-TK Renilla vector together with E2F1 siRNA. After 36 h of transfection, the luciferase activity was detected by the Dual-Luciferase Reporter Assay System (Promega, USA),and the Firefly luciferase activity was normalized to the Renilla luciferase activity.

    RNA extraction and reverse transcription-quantitative polymerase chain reaction (RT-qPCR)

    Total RNA from ESCC cells was purified using RNAiso plus (Takara, Dalian, China). Complementary DNA(cDNA) was synthesized from 1 μg of total RNA using a PrimeScript?RT reagent Kit with gDNA Eraser (Takara).TB Green?Premix Ex Taq?II kit (Takara) was used to detect the indicated RNA levels on the QuantStudio Real-Time PCR System (Applied Biosystems, USA) or the CFX96 Real-Time System (Bio-Rad, USA). The relative expression levels of the target genes were normalized to endogenous GAPDH. The primers synthesized by Invitrogen are listed in Supplementary Table S1.

    Western blot

    Total protein from ESCC cells was extracted using RIPA lysis buffer (Proteintech Group, Wuhan, China) that was supplemented with the protease inhibitor PMSF and was quantified by Enhanced BCA Protein Assay Kit (Beyotime Institute of Biotechnology, Shanghai, China) following the manufacturer's protocols. Equal quantities of proteins were separated by 10% SDS-PAGE and were transferred onto PVDF membranes. After blocking in 5% non-fat milk for 1 h, the membrane was then incubated with E2F1 primary antibody (ab179445; Abcam) at 4 °C overnight. Protein bands were detected using a horseradish-peroxidase(HRP)-conjugated IgG secondary antibody (Proteintech Group), and images were captured with the BioSpectrum imaging system (UVP, USA). GAPDH (60004-1-lg;Proteintech Group) was used as loading control.

    In-cell western assay

    Cells grown in 96-well plates were fixed with 3.7%formaldehyde for 20 min and were permeabilized using 0.1% Triton X-100. After blocking with 5% non-fat milk for 1 h, cells were incubated with a mixture of FAT1 primary antibody (ab190242; Abcam, UK) and GAPDH primary antibody (60004-1-lg; Proteintech Group, China)overnight at 4 °C. Then, cells were washed with PBST and were incubated with 680 nm and 800 nm infrared-labeled secondary antibody solutions (LI-COR Biosciences, USA)for 1 h at room temperature. Fluorescent signals for FAT1 and GAPDH were captured using the Odyssey infrared imaging system (LI-COR Biosciences, Lincoln, Nebraska,USA). Finally, the relative abundance of the FAT1 protein was normalized to GAPDH.

    Transwell migration/invasion assays

    Transwell migration and invasion assays were performed using a Transwell plate (Corning, New York, USA) that was coated with (for invasion) or without (for migration)Matrigel Basement Membrane Matrix (BD). Briefly,1.5×105cells were seeded into the upper chamber of Transwell with serum-free medium, while culture medium with 20% FBS was added to the lower chamber. After culturing for 12-24 h, cells that migrated or invaded though the membrane were fixed with methanol for 10 min, stained with crystal violet solution for 5 min and finally photographed under a microscope (Leica,Germany).

    Colony formation assay

    A total of 1,000-3,000 transfected cells per well were seeded into plates containing medium with 10% FBS on d 0, and the cells were incubated at 37 °C with 5% CO2for 14 d. On d 14, the cells were washed with PBS, fixed with methanol for 10 min and then stained with crystal violet solution for another 10 min. After washing with water and drying at room temperature, the colonies were photographed and counted.

    RNA sequencing (RNA-seq)

    The transcriptome sequencing profiles of KSYE30-control and KYSE30-siFAT1 cells were obtained to detect the altered expression of downstream genes. Briefly,sequencing libraries were constructed with NEBNext Ultra RNA Library Prep Kit for Illumina (NEB, Ipswich, USA)

    according to manufacturer's protocols. The libraries were sequenced on the Illumina HiSeq platform by Novogene(Beijing, China). Clean data were then mapped to the human reference genome hg19. The Fragments Per Kilobase of exon per Million mapped fragments (FPKM) of each gene was calculated and differential expression analysis was performed. The significantly differentially expressed genes between the control cells and the FAT1 depleted cells were input to DAVID database (33,34) and enriched using Kyoto Encyclopedia of Genes and Genomes(KEGG) (35) and Gene Ontology (GO) analyses.

    Statistical analysis

    The data are presented as the. P<0.05 was considered statistically significant. The data were statistically analyzed using GraphPad Prism 6 (GraphPad Software, San Diego,CA, USA) by means of a two-sided Student's t-test.

    Results

    FAT1 exhibits a high frequency of genetic alterations in ESCC

    To comprehensively explore the genetic alterations of FAT1 in ESCC, we first analyzed the somatic mutations of FAT1 from a study by Du et al. (36), which consisted of a total of 41 whole-genome sequences and 449 whole-exome sequences from seven published ESCC genomic data (7-10,37-39). We observed that FAT1 was frequently mutated in ESCC (Figure 1A). The mutation rate of FAT1 was 10%(49/490), and most of the mutations, including missense,truncating or inframe, occurred in the cadherin domains.

    Figure 1 FAT1 exhibits genetic alterations with high frequency in esophageal squamous cell carcinoma (ESCC). (A) Frequency of FAT1 mutations in ESCC. Green box, cadherin domain; Red box, laminin G-like domain; Blue box, epidermal growth factor (EGF)-like domain;Yellow box, calcium-binding EGF domain; Black ball, truncating mutation; Green ball, missense mutation; Brown ball, inframe mutation;Pink ball, other mutation; (B) Frequency of FAT1 copy number variants (CNVs) in three types of squamous cell carcinomas and tumor cell lines. The percentage represents the approximate ratio of CNVs. Red box, amplification; Blue box, deletion. LUSCC, lung squamous cell carcinoma; HNSCC, head and neck squamous cell carcinoma; TC, tumor cell lines.

    Furthermore, we analyzed the CNV features of FAT1 in 154 ESCC patients from our previous studies (7,10) and found that CNVs of FAT1 were altered in ESCC (Figure 1B).The total CNV rate, including the amplification of 1/154(0.6%) and the deletion of 18/154 (11.7%), was approximately 12.3% (19/154). We also consulted The Cancer Genome Atlas (TCGA) database (40) and observed similar CNV features for FAT1 in lung squamous cell carcinoma (LUSCC) and head and neck squamous cell carcinoma (HNSCC) using the cBioPortal (41,42) (Figure 1B). In LUSCC, the total CNV rate was approximately 6.8% (34/501), consisting of the amplification of 3/501(0.6%) and the deletion of 31/501 (6.2%). Consistently, in HNSCC, the total CNV rate was approximately 7.9%(41/522), consisting of the amplification of 3/522 (0.6%)and the deletion of 38/522 (7.3%). In addition, we analyzed the CNV rate of FAT1 in 995 tumor cell lines (TC) from the Cancer Cell Line Encyclopedia (CCLE) database (43)using the cBioPortal and found that the total CNV rate of FAT1 in the pan tumor cell lines was approximately 7.2%(72/995), including the amplification of 16/995 (1.6%) and the deletion of 56/995 (5.6%) (Figure 1B). Taken together,our results revealed frequent inactivation of FAT1 via mutations or deletions in ESCC and multiple other human cancers.

    FAT1 expression is regulated by transcription factor E2F1

    It is reported that FAT1 expression is downregulated in ESCC tissues (9,13,14). In addition to the genetic alterations described above, we hypothesized that transcriptional regulation may also play an important role in this process. To test this, we consulted the encyclopedia of DNA elements (ENCODE) database (44) and observed a putative binding site for the transcription factor E2F1 on the promoter region of FAT1 with the following identifiers:ENCFF000XCY, ENCFF000XEQ and ENCFF000ZLB(Figure 2A). Thus, a ChIP assay, using an E2F1 antibody,was then employed to confirm this occupancy. As expected,we observed a strong enrichment of E2F1 at the promoter region of FAT1 when compared with that in IgG control(Figure 2B).

    Figure 2 E2F1 regulates FAT1 transcription. (A) Putative binding sites of E2F1 on the FAT1 promoter region from different cohorts in encyclopedia of DNA elements (ENCODE) database. Red box represents binding reads of E2F1; (B) Enrichment of E2F1 on FAT1 promoter in KYSE30 cells shown by chromatin immunoprecipitation (ChIP) and quantitative polymerase chain reaction (qPCR).Enrichment is determined as the amount of FAT1 promoter associated to E2F1 relative to immunoglobulin G (IgG) control; (C) Luciferase activity of pGL3-FAT1 vector was measured in KYSE30 cells upon E2F1 knockdown. Data are presented as ratio of the firefly luciferase activity to Renilla luciferase activity; RT-qPCR (D) and Western blot (E) analyses of E2F1 expression in KYSE30 cells upon E2F1 knockdown. Relative RNA levels of E2F1 were normalized to endogenous GAPDH; (F) RT-qPCR analysis of FAT1 expression in KYSE30 cells as described in (D). Relative RNA levels of FAT1 were normalized to endogenous GAPDH. *, P<0.05; **, P<0.01; ***, P<0.001 vs.control.

    To ascertain whether E2F1 regulates the transcription of FAT1, we constructed a luciferase reporter, namely pGL3-FAT1, which contained the promoter region of FAT1. The luciferase activity of pGL3-FAT1 was much higher than the control vector upon transfection into KYSE30 cells,and this increased luciferase activity was inhibited by siRNA-mediated E2F1 knockdown (Figure 2C).Meanwhile, knockdown of E2F1 reduced FAT1 mRNA levels in KYSE30 cells (Figure 2F). The knockdown efficiency of E2F1 at the mRNA and protein levels was confirmed by RT-qPCR (Figure 2D) and Western blot(Figure 2E), respectively. Collectively, these results showed that E2F1 binds to the FAT1 promoter to activate its transcription in ESCC cells.

    Downregulation of FAT1 promotes ESCC cell proliferation,migration and invasion

    To explore the biological roles of FAT1, we performed a loss-of-function study using two small interfering RNAs(siRNAs) to knock down the FAT1 in KYSE30 and KYSE150 cell lines. RT-qPCR and In-cell western assays showed that the two siRNAs effectively downregulated both mRNA and protein levels of FAT1, when compared with the control siRNA (Figure 3A,B). The colony formation and Transwell assays were used to elucidate the effects of FAT1 knockdown on ESCC cell proliferation,migration and invasion. As shown in Figure 3C,D, the cells transfected with siRNAs targeting FAT1 exhibited an enhanced colony formation ability compared with the control siRNA transfected cells. Taking advantage of the Transwell system, we validated that knockdown of FAT1 enhanced the migration and invasion abilities of KYSE30 and KYSE150 cells (Figure 3E-H). Taken together, these results demonstrated that FAT1 knockdown strengthened the aggressive potential of ESCC cells.

    Overexpression of FAT1 inhibits ESCC cell proliferation,migration and invasion

    To test the gain-of-function of FAT1 in ESCC cell lines,we transfected FAT1 into KYSE30 and KYSE410 cell lines using an expression vector with all the key functional domains of FAT1 (truncated FAT1, which was named FAT1-Trunc) (18). The mRNA and protein levels of FAT1 were monitored by RT-qPCR and In-cell western assays,respectively (Figure 4A,B). FAT1 overexpression reduced the colony formation abilities of KYSE30 and KYSE410 cells compared with the control empty vector (Figure 4C,D). Furthermore, the Transwell assays revealed that FAT1 overexpression greatly attenuated the migration and invasion abilities of KYSE30 and KYSE410 cells (Figure 4E-H). Collectively, the results of both the loss-of-function and gain-of-function studies demonstrated that FAT1 may act as a tumor suppressor in ESCC.

    FAT1 is involved in mitogen-activated protein kinase(MAPK) signaling pathway and cell adhesion process in ESCC cells

    Figure 3 FAT1 knockdown promotes KYSE30 and KYSE150 cell migration, invasion and proliferation. Reverse transcription-quantitative polymerase chain reaction (RT-qPCR) (A) and In-cell western analyses (B) of FAT1 expression in KYSE30 and KYSE150 cells upon FAT1 knockdown. Relative RNA and protein levels of FAT1 were normalized to endogenous GAPDH; (C, D) KYSE30 and KYSE150 cells were transfected with the indicated siRNAs. After 24 h of transfection, cells were subject to colony formation assay. Representative results (C)and corresponding quantification (D) are shown (Scale bar =2 mm); (E-H) Representative results of Transwell migration/invasion assays and corresponding quantification in KYSE30 (E, F) and KYSE150 (G, H) cells after transfected with indicated siRNAs as described in (C,D) (Scale bar =100 μm). *, P<0.05; **, P<0.01; ***, P<0.001 vs. control.

    To investigate the molecular mechanism of FAT1 in ESCC oncogenesis, we performed a RNA-seq analysis using control and FAT1 knocked-down KYSE30 cells, and subsequently analyzed the altered gene expression profiles(Supplementary Table S2). The KEGG pathway enrichment analysis revealed that upon FAT1 knockdown, the significantly differentially expressed genes were enriched in multiple pathways, including the MAPK signaling pathway and cell adhesion molecules (CAMs) (Figure 5A). The GO functional analysis showed that these genes were enriched in biological processes, including the cell adhesion, cell-cell signaling and epidermis development (Figure 5B). Genes involved in the MAPK signaling pathway and the cell adhesion process were selected and validated by RT-qPCR after the knockdown of FAT1 in KYSE30 cells. As expected,FAT1 knockdown induced the mRNA levels of MAP3K8,MAP2K2 and MAP2K6 and decreased the mRNA level of MAPK inactivator DUSP6 (Figure 5C). Meanwhile, FAT1 knockdown enhanced the mRNA levels of L1CAM and CDH5, which are involved in the cell adhesion process(Figure 5D). In conclusion, these results indicated that FAT1 is involved in the MAPK signaling pathway and the cell adhesion process in ESCC cells.

    Discussion

    ESCC is one of the most prevalent malignant tumors in China, with an elusive cancerogenesis and a poor prognosis(3,6). To study the molecular mechanism of ESCC tumorigenesis, several large-scale genomic sequencing studies have attempted to uncover the driving genomic variations (7-11). Interestingly, FAT1 is frequently subject to inactivating mutations in ESCC (8-11), which is accompanied by loss of heterozygosity or homozygous deletion (9,11). Given that the case number of ESCC in each of these studies is relatively small, we analyzed the mutations of FAT1 by using data that was combined from different cohorts by Du et al. (36) and revealed that FAT1 was indeed frequently mutated in ESCC. Furthermore, we analyzed the FAT1 CNV using our previous data (7,10) and databases, and the results showed a deletion of FAT1 in ESCC and other cancers. Although the function of FAT1 in tumorigenesis is still under debate in different types of tumors (18-21), it is considered a tumor suppressor gene in ESCC (9,13,14). Consistently, in this study, the in vitro experiments revealed that upregulation of FAT1 inhibited ESCC cell proliferation, migration and invasion, while FAT1 exhaustion resulted in the opposite effects. Thus, our study supplements the current theories that FAT1 shows mutations and deletions in ESCC and acts as a tumor suppressor gene.

    Figure 4 FAT1 overexpression suppresses KYSE30 and KYSE410 cell proliferation, migration and invasion. Reverse transcriptionquantitative polymerase chain reaction (RT-qPCR) (A) and In-cell western analyses (B) of FAT1 expression in KYSE30 and KYSE410 cells upon FAT1 overexpression. Relative RNA and protein levels of FAT1 were normalized to endogenous GAPDH; (C, D) KYSE30 and KYSE410 cells were transfected with indicated vectors. After 24 h of transfection, cells were subject to colony formation assay.Representative results (C) and corresponding quantification (D) are shown (Scale bar =4 mm); (E-H) Representative results of Transwell migration/invasion assays and the corresponding quantification in KYSE30 (E, F) and KYSE410 (G, H) cells after transfected with the indicated vectors as described in (C, D) (Scale bar =100 μm). *, P<0.05; **, P<0.01; ***, P<0.001 vs. control.

    In addition to the dysregulation caused by the genetic alterations, an alternative possibility is that transcription is changed during tumorigenesis. To illustrate the transcriptional regulation of FAT1 mRNA expression in ESCC cells, we consulted the ENCODE database and found that the FAT1 promoter region was occupied by transcription factor E2F1 in several ChIP-seq projects. E2F1 is an important transcription factor that regulates the gene expression in multiple types of human cancers and has both oncogenic and tumor-suppressive properties (45-48).Matrix metalloproteinase (MMP) genes are direct transcriptional targets of E2F1 in non-small cell lung cancer (NSCLC) cell lines (49). E2F1 binds to the promoter region of the phosphatase of activated cells 1(PAC1) and actives its transcription in breast cancer cells(50). Nevertheless, little is known about the transcriptional regulatory effects of E2F1 in ESCC. Here, we characterized the binding and transcription activity of E2F1 upon the FAT1 promoter region, as well as the influence of E2F1 on FAT1 mRNA levels, and thus identified FAT1 as a transcriptional target of E2F1 in ESCC cells.

    The results of RNA-seq and RT-qPCR revealed that FAT1 knockdown resulted in the altered expression of package of genes that are involved in the MAPK signaling pathway, which is consistent with previous report (13). The MAPK signaling pathway is an important signaling component that consists of a set of evolutionarily conserved kinase cascades from yeast to human, including MAPK kinase kinase kinase (MKKK), MAPK kinase kinase (MKK)and MAPK (51,52). It is reported that the MAPK pathway is dysregulated in ESCC and may function as an oncogene in ESCC tumorigenesis (53,54). On the other hand, the GO functional analysis and RT-qPCR also revealed that loss of FAT1 subsequently upregulated the expression of genes that participate in the cell adhesion process,including L1CAM and CHD5, which may play roles in the progression or metastasis of multiple cancers and correlate with poor outcomes (55-58). Collectively, the RNA-seq results revealed that FAT1 knockdown led to the abnormal expression of genes in the MAPK signaling pathway and cell adhesion process, further indicating that FAT1 is involved in ESCC tumorigenesis

    Figure 5 Global transcriptional identification of genes regulated by FAT1. KYSE30 cells were transfected with FAT1 siRNA or scramble control siRNA. After 48 h of transfection, cells were collected and subject to RNA-seq. Kyoto Encyclopedia of Genes and Genomes(KEGG) pathway enrichment analysis (A) and Gene Ontology (GO) functional analysis (B) of significantly differently expressed genes upon FAT1 knockdown in KYSE30 cells; Reverse transcription-quantitative polymerase chain reaction (RT-qPCR) showing the expression of genes involved in mitogen-activated protein kinase (MAPK) signal pathway (C) and cell adhesion process in KYSE30 cells after 48 h of transfection with the indicated siRNAs (D). Relative RNA levels of genes were normalized to endogenous GAPDH. *, P<0.05; **, P<0.01;***, P<0.001 vs. control.

    Conclusions

    In this study we identified FAT1 as the transcriptional target of E2F1. Moreover, we also validated that FAT1 exhibits tumor suppressive function in ESCC and participates in the MAPK signaling pathway and cell adhesion process. These results advance our understanding of mechanisms by which FAT1 is inactive and regulated in ESCC, and the data also highlight the importance of FAT1 in ESCC tumorigenesis.

    Acknowledgements

    This work was supported by the National Basic Research Program of China (973 Program) (No. 2015CB553906 and 2015CB553904), the National Natural Science Foundation of China (No. 81490753 and 81830086) and the Education Department of Liaoning Province in China (Scientific Research Projects, No. L2016038).

    Footnote

    Conflicts of Interest: The authors have no conflicts of interests to declare.

    97在线人人人人妻| 国产亚洲最大av| 国产成人精品无人区| 午夜福利在线观看免费完整高清在| 麻豆成人av视频| 十八禁网站网址无遮挡| 亚洲精品久久成人aⅴ小说 | 欧美激情 高清一区二区三区| 夜夜爽夜夜爽视频| 国产亚洲精品第一综合不卡 | 亚洲欧美日韩另类电影网站| 一级黄片播放器| a 毛片基地| a级毛片黄视频| 在线 av 中文字幕| 丰满少妇做爰视频| 午夜91福利影院| 人妻人人澡人人爽人人| 丰满少妇做爰视频| 亚洲av免费高清在线观看| 2021少妇久久久久久久久久久| 丰满少妇做爰视频| 午夜福利影视在线免费观看| 色婷婷久久久亚洲欧美| av在线播放精品| 一区二区三区四区激情视频| 制服人妻中文乱码| 国产精品女同一区二区软件| 黑人高潮一二区| 免费观看a级毛片全部| 欧美日韩成人在线一区二区| 人体艺术视频欧美日本| 久久毛片免费看一区二区三区| 天堂俺去俺来也www色官网| 国产精品一区www在线观看| 啦啦啦中文免费视频观看日本| 国产成人a∨麻豆精品| 国语对白做爰xxxⅹ性视频网站| 一区二区三区免费毛片| 9色porny在线观看| 色吧在线观看| 精品久久久久久电影网| 七月丁香在线播放| xxx大片免费视频| 精品久久蜜臀av无| 亚洲国产精品一区三区| 日日爽夜夜爽网站| 国产亚洲精品久久久com| 亚洲av免费高清在线观看| 亚洲人与动物交配视频| 三级国产精品片| 性色av一级| 纯流量卡能插随身wifi吗| 亚洲不卡免费看| 精品亚洲成国产av| 成年女人在线观看亚洲视频| 日韩欧美一区视频在线观看| 赤兔流量卡办理| 国产欧美亚洲国产| 99国产综合亚洲精品| 成人毛片60女人毛片免费| 国产永久视频网站| 婷婷色麻豆天堂久久| 国产精品偷伦视频观看了| 美女主播在线视频| 七月丁香在线播放| 久久久精品94久久精品| 久久国产亚洲av麻豆专区| 国模一区二区三区四区视频| 欧美日韩国产mv在线观看视频| 亚洲国产色片| 国产成人aa在线观看| 丰满饥渴人妻一区二区三| 丝瓜视频免费看黄片| 久久狼人影院| 亚洲第一av免费看| 在线观看免费视频网站a站| 午夜福利视频在线观看免费| 亚洲欧美色中文字幕在线| 日韩在线高清观看一区二区三区| 欧美变态另类bdsm刘玥| 国产日韩欧美在线精品| 日日摸夜夜添夜夜添av毛片| 国产精品.久久久| 尾随美女入室| 国产爽快片一区二区三区| 热99国产精品久久久久久7| 久久午夜综合久久蜜桃| 菩萨蛮人人尽说江南好唐韦庄| 亚洲精品aⅴ在线观看| 欧美人与善性xxx| av在线老鸭窝| 欧美丝袜亚洲另类| 国产成人a∨麻豆精品| av又黄又爽大尺度在线免费看| 亚洲精品视频女| 国产精品.久久久| 国产一区有黄有色的免费视频| 久久久久视频综合| 亚洲综合色网址| 国产精品欧美亚洲77777| 国产精品国产三级国产av玫瑰| 美女国产视频在线观看| 国产精品国产三级国产专区5o| 亚洲精品国产av成人精品| 精品人妻熟女av久视频| 国产69精品久久久久777片| 中文字幕制服av| 国产高清三级在线| kizo精华| 黄色一级大片看看| 男女免费视频国产| 亚洲激情五月婷婷啪啪| 亚洲熟女精品中文字幕| 成人国产麻豆网| 日韩av免费高清视频| 成人漫画全彩无遮挡| 啦啦啦中文免费视频观看日本| 久久精品久久精品一区二区三区| 亚洲成人手机| 欧美 亚洲 国产 日韩一| 国产亚洲一区二区精品| 亚洲精品一区蜜桃| 中文字幕久久专区| 亚洲国产日韩一区二区| 精品国产一区二区三区久久久樱花| 亚洲av欧美aⅴ国产| 欧美日韩成人在线一区二区| 视频区图区小说| 久久人人爽人人爽人人片va| 青春草亚洲视频在线观看| 美女内射精品一级片tv| 一本一本综合久久| 在线观看www视频免费| 久久狼人影院| 麻豆成人av视频| 国产熟女欧美一区二区| 亚洲成人手机| 婷婷色综合www| 国产日韩欧美视频二区| 亚洲精品一区蜜桃| 欧美变态另类bdsm刘玥| 成人亚洲精品一区在线观看| 满18在线观看网站| 日本午夜av视频| 精品午夜福利在线看| 亚洲欧洲精品一区二区精品久久久 | 久久ye,这里只有精品| 黄片播放在线免费| 能在线免费看毛片的网站| 久久久久国产精品人妻一区二区| 中文字幕亚洲精品专区| 在线观看一区二区三区激情| 熟女av电影| 女人久久www免费人成看片| 久久99一区二区三区| 国产午夜精品久久久久久一区二区三区| 亚洲美女视频黄频| 男女边吃奶边做爰视频| 一区二区三区四区激情视频| 在线 av 中文字幕| 中文字幕亚洲精品专区| 久久婷婷青草| 欧美激情极品国产一区二区三区 | 黄色一级大片看看| 高清黄色对白视频在线免费看| 亚洲熟女精品中文字幕| 亚洲综合色网址| 美女内射精品一级片tv| 99热全是精品| 国产日韩欧美亚洲二区| 18+在线观看网站| 欧美日韩一区二区视频在线观看视频在线| 欧美精品一区二区免费开放| 少妇人妻久久综合中文| 久久久精品94久久精品| 视频中文字幕在线观看| 中文乱码字字幕精品一区二区三区| 国产爽快片一区二区三区| 考比视频在线观看| 亚洲经典国产精华液单| 久久99蜜桃精品久久| 国产男女内射视频| 国产精品久久久久久av不卡| 少妇的逼水好多| 精品酒店卫生间| 日韩av不卡免费在线播放| 亚州av有码| 美女福利国产在线| 韩国高清视频一区二区三区| av又黄又爽大尺度在线免费看| 波野结衣二区三区在线| 青青草视频在线视频观看| 我的女老师完整版在线观看| 亚洲熟女精品中文字幕| 精品国产乱码久久久久久小说| 亚洲精品一二三| 日本黄色日本黄色录像| av在线老鸭窝| 97超碰精品成人国产| 久久久久久久亚洲中文字幕| 国产老妇伦熟女老妇高清| 国产综合精华液| 国产日韩欧美视频二区| 麻豆乱淫一区二区| 九九爱精品视频在线观看| 亚洲丝袜综合中文字幕| 97超碰精品成人国产| 99精国产麻豆久久婷婷| 亚洲成色77777| 日韩视频在线欧美| 国产乱人偷精品视频| 97在线人人人人妻| 18禁裸乳无遮挡动漫免费视频| 18禁观看日本| 能在线免费看毛片的网站| 国产精品三级大全| 亚洲内射少妇av| 国产成人免费观看mmmm| 美女主播在线视频| 伦理电影免费视频| 国产高清有码在线观看视频| 国产老妇伦熟女老妇高清| 欧美成人精品欧美一级黄| 91精品国产九色| 久久久久久久久久久丰满| 99久久人妻综合| 久久亚洲国产成人精品v| 久久毛片免费看一区二区三区| 久久这里有精品视频免费| 十八禁网站网址无遮挡| 国产一区有黄有色的免费视频| 亚洲精品一二三| 欧美+日韩+精品| 精品久久久噜噜| 99久久综合免费| 国产精品人妻久久久影院| 丰满迷人的少妇在线观看| 亚洲综合色网址| 伦理电影免费视频| 9色porny在线观看| 男人爽女人下面视频在线观看| 免费看av在线观看网站| 久久精品国产a三级三级三级| 色5月婷婷丁香| 免费大片黄手机在线观看| 亚洲欧美精品自产自拍| 男女边摸边吃奶| 人成视频在线观看免费观看| 久久久亚洲精品成人影院| 久久99精品国语久久久| 国产国拍精品亚洲av在线观看| 简卡轻食公司| 麻豆精品久久久久久蜜桃| 国产精品久久久久久久久免| 如何舔出高潮| 国产成人精品一,二区| 少妇的逼水好多| 在线观看免费视频网站a站| 大话2 男鬼变身卡| 婷婷色麻豆天堂久久| 91精品三级在线观看| 看免费成人av毛片| 国产成人精品久久久久久| 亚洲精品亚洲一区二区| 久久久久精品久久久久真实原创| 亚洲av男天堂| 精品午夜福利在线看| 黑人猛操日本美女一级片| 天美传媒精品一区二区| 老司机影院成人| 另类精品久久| 国产精品国产av在线观看| 少妇高潮的动态图| 成人亚洲欧美一区二区av| 日韩熟女老妇一区二区性免费视频| 你懂的网址亚洲精品在线观看| 永久网站在线| 成人手机av| 久久精品国产自在天天线| 一边亲一边摸免费视频| 亚洲av电影在线观看一区二区三区| 好男人视频免费观看在线| 亚洲精品日本国产第一区| 久久精品久久久久久久性| 国产不卡av网站在线观看| 国产毛片在线视频| 国产男女超爽视频在线观看| av在线观看视频网站免费| 亚洲怡红院男人天堂| 国产亚洲最大av| 国产精品久久久久久av不卡| 有码 亚洲区| 一区二区三区四区激情视频| 777米奇影视久久| 国产免费一区二区三区四区乱码| 一本一本综合久久| 日本91视频免费播放| 一本一本久久a久久精品综合妖精 国产伦在线观看视频一区 | 国产成人午夜福利电影在线观看| 99国产精品免费福利视频| 午夜福利网站1000一区二区三区| a级毛片在线看网站| 2022亚洲国产成人精品| 中文欧美无线码| 最近最新中文字幕免费大全7| 亚洲内射少妇av| 最近2019中文字幕mv第一页| 午夜激情福利司机影院| a级毛色黄片| 欧美3d第一页| 日韩成人伦理影院| 一级,二级,三级黄色视频| 亚洲精品色激情综合| 日日夜夜操网爽| 97人妻天天添夜夜摸| 久久国产精品男人的天堂亚洲| 精品人妻熟女毛片av久久网站| 亚洲av欧美aⅴ国产| 精品熟女少妇八av免费久了| 中文字幕最新亚洲高清| 国产在视频线精品| 国产成人欧美| 亚洲精品粉嫩美女一区| 国产亚洲精品久久久久5区| 后天国语完整版免费观看| √禁漫天堂资源中文www| 亚洲成人手机| 国产精品久久久久久精品古装| 欧美黑人精品巨大| 亚洲欧美一区二区三区黑人| 亚洲第一欧美日韩一区二区三区 | 国产在线精品亚洲第一网站| 老熟妇乱子伦视频在线观看| 国产又爽黄色视频| 国产欧美日韩一区二区三| 色94色欧美一区二区| 在线观看免费午夜福利视频| svipshipincom国产片| 99国产精品一区二区蜜桃av | 久久精品成人免费网站| 欧美一级毛片孕妇| 激情在线观看视频在线高清 | 每晚都被弄得嗷嗷叫到高潮| 国产亚洲欧美在线一区二区| 如日韩欧美国产精品一区二区三区| 精品欧美一区二区三区在线| 另类精品久久| 久久久国产精品麻豆| 久久午夜亚洲精品久久| 精品一区二区三区av网在线观看 | 亚洲国产毛片av蜜桃av| 极品教师在线免费播放| 国产精品美女特级片免费视频播放器 | cao死你这个sao货| 少妇的丰满在线观看| 一本综合久久免费| 亚洲国产毛片av蜜桃av| 久久中文字幕人妻熟女| 精品欧美一区二区三区在线| 国产视频一区二区在线看| 大陆偷拍与自拍| 午夜久久久在线观看| 老熟妇仑乱视频hdxx| 国产精品二区激情视频| 99riav亚洲国产免费| 最近最新中文字幕大全电影3 | 亚洲av成人不卡在线观看播放网| 欧美日本中文国产一区发布| 嫁个100分男人电影在线观看| 久久99热这里只频精品6学生| 成人特级黄色片久久久久久久 | 亚洲精品中文字幕一二三四区 | 亚洲欧美色中文字幕在线| 久久中文字幕人妻熟女| 国产成人免费观看mmmm| 亚洲中文日韩欧美视频| 一个人免费看片子| 国产成人精品在线电影| 18禁黄网站禁片午夜丰满| 99国产精品一区二区三区| 99久久人妻综合| 极品教师在线免费播放| 大片电影免费在线观看免费| 亚洲va日本ⅴa欧美va伊人久久| 天天影视国产精品| 69av精品久久久久久 | 精品国产一区二区三区四区第35| tocl精华| 水蜜桃什么品种好| 美女高潮喷水抽搐中文字幕| 亚洲熟女精品中文字幕| 99精品在免费线老司机午夜| 精品亚洲成a人片在线观看| 欧美日韩亚洲综合一区二区三区_| 99热网站在线观看| www日本在线高清视频| 欧美变态另类bdsm刘玥| 欧美乱妇无乱码| 午夜福利视频精品| 新久久久久国产一级毛片| 色精品久久人妻99蜜桃| 午夜免费鲁丝| 免费黄频网站在线观看国产| 精品国产一区二区三区久久久樱花| 日本一区二区免费在线视频| 丝袜美足系列| 久久久久久久大尺度免费视频| 性高湖久久久久久久久免费观看| av片东京热男人的天堂| 中文字幕精品免费在线观看视频| 日韩欧美一区视频在线观看| 成人黄色视频免费在线看| 黑人欧美特级aaaaaa片| 精品国产超薄肉色丝袜足j| 天堂动漫精品| 欧美日韩一级在线毛片| 国产精品久久久久成人av| 国产日韩欧美在线精品| 国产精品 国内视频| 国精品久久久久久国模美| 999久久久国产精品视频| 亚洲人成77777在线视频| 国产区一区二久久| 久久久久精品国产欧美久久久| 日本黄色视频三级网站网址 | 一个人免费看片子| 亚洲国产精品一区二区三区在线| 色综合欧美亚洲国产小说| 一边摸一边做爽爽视频免费| 日韩欧美三级三区| 操出白浆在线播放| 午夜日韩欧美国产| 午夜福利视频在线观看免费| 在线看a的网站| 91大片在线观看| 亚洲国产成人一精品久久久| 女性生殖器流出的白浆| 亚洲国产欧美在线一区| 国产精品98久久久久久宅男小说| 国产一卡二卡三卡精品| 波多野结衣一区麻豆| 亚洲成人手机| 久久国产精品男人的天堂亚洲| 久久久久久久久久久久大奶| 国产精品欧美亚洲77777| 日韩制服丝袜自拍偷拍| 黄色视频,在线免费观看| 国产激情久久老熟女| 国产无遮挡羞羞视频在线观看| 欧美激情 高清一区二区三区| 日韩中文字幕视频在线看片| 好男人电影高清在线观看| 免费观看av网站的网址| av网站在线播放免费| 精品国产亚洲在线| av有码第一页| 亚洲综合色网址| 亚洲五月色婷婷综合| 狠狠婷婷综合久久久久久88av| 极品人妻少妇av视频| 在线十欧美十亚洲十日本专区| 考比视频在线观看| av福利片在线| 国产视频一区二区在线看| 午夜福利免费观看在线| 无人区码免费观看不卡 | 自线自在国产av| 亚洲av日韩在线播放| 久久人人爽av亚洲精品天堂| 亚洲 国产 在线| 亚洲人成电影观看| 国产成人免费无遮挡视频| 欧美av亚洲av综合av国产av| 午夜精品久久久久久毛片777| 久久精品亚洲精品国产色婷小说| 人妻 亚洲 视频| 国产欧美日韩一区二区精品| 女性被躁到高潮视频| 蜜桃在线观看..| 亚洲人成伊人成综合网2020| av免费在线观看网站| 国产午夜精品久久久久久| 欧美大码av| 国产在线一区二区三区精| 亚洲精品自拍成人| 久久国产亚洲av麻豆专区| 成年动漫av网址| 精品熟女少妇八av免费久了| 国产精品国产高清国产av | 午夜福利欧美成人| 欧美日韩福利视频一区二区| 国产亚洲一区二区精品| 男女边摸边吃奶| 一本久久精品| 99精品欧美一区二区三区四区| 亚洲国产av影院在线观看| 超碰97精品在线观看| 狠狠婷婷综合久久久久久88av| 啦啦啦视频在线资源免费观看| 免费少妇av软件| 亚洲免费av在线视频| 亚洲熟女毛片儿| 久久精品人人爽人人爽视色| 高清在线国产一区| 极品少妇高潮喷水抽搐| 在线观看免费日韩欧美大片| 国产成+人综合+亚洲专区| 中文字幕人妻丝袜一区二区| 欧美一级毛片孕妇| 欧美+亚洲+日韩+国产| 男女边摸边吃奶| 亚洲专区字幕在线| 亚洲av美国av| 大片电影免费在线观看免费| 999久久久国产精品视频| 母亲3免费完整高清在线观看| 精品少妇内射三级| 国产av一区二区精品久久| 无人区码免费观看不卡 | 99国产综合亚洲精品| 国产精品一区二区在线不卡| tube8黄色片| 国产成人免费观看mmmm| 国产亚洲一区二区精品| 日本a在线网址| 日日爽夜夜爽网站| 80岁老熟妇乱子伦牲交| 亚洲国产av新网站| 亚洲专区国产一区二区| 天天操日日干夜夜撸| 99久久99久久久精品蜜桃| 亚洲成av片中文字幕在线观看| 成人三级做爰电影| 中文字幕制服av| 亚洲五月婷婷丁香| 欧美性长视频在线观看| 国产免费现黄频在线看| 免费av中文字幕在线| 新久久久久国产一级毛片| 成人黄色视频免费在线看| 下体分泌物呈黄色| 亚洲性夜色夜夜综合| 亚洲精品国产色婷婷电影| 久久狼人影院| 久久久久久亚洲精品国产蜜桃av| 亚洲精品国产区一区二| 国产成人精品无人区| 精品久久久精品久久久| 亚洲久久久国产精品| √禁漫天堂资源中文www| 日韩成人在线观看一区二区三区| 欧美日韩福利视频一区二区| 麻豆成人av在线观看| 久久亚洲真实| 少妇 在线观看| 一级片免费观看大全| 老司机深夜福利视频在线观看| 久久中文字幕人妻熟女| 国产成人免费无遮挡视频| a级片在线免费高清观看视频| 欧美一级毛片孕妇| tube8黄色片| 国产激情久久老熟女| 国产精品久久久人人做人人爽| 国产成人啪精品午夜网站| 丁香欧美五月| 日韩一卡2卡3卡4卡2021年| 黑人巨大精品欧美一区二区蜜桃| 高清毛片免费观看视频网站 | 十八禁高潮呻吟视频| 国产极品粉嫩免费观看在线| 午夜视频精品福利| 欧美日韩福利视频一区二区| 悠悠久久av| 免费人妻精品一区二区三区视频| 水蜜桃什么品种好| 国产亚洲精品久久久久5区| 香蕉久久夜色| 成人亚洲精品一区在线观看| 高潮久久久久久久久久久不卡| 久久天堂一区二区三区四区| 午夜成年电影在线免费观看| 两个人免费观看高清视频| 欧美日韩亚洲国产一区二区在线观看 | 国内毛片毛片毛片毛片毛片| 亚洲欧美一区二区三区久久| 国产三级黄色录像| 一级毛片精品| 91精品三级在线观看| 最近最新中文字幕大全电影3 | 国内毛片毛片毛片毛片毛片| 亚洲午夜理论影院| 国产精品九九99| 人成视频在线观看免费观看| www日本在线高清视频| 欧美在线一区亚洲| 国产成+人综合+亚洲专区| 欧美激情高清一区二区三区| 窝窝影院91人妻| 国产在线免费精品| 一区二区三区国产精品乱码| 大香蕉久久网| 精品高清国产在线一区| 捣出白浆h1v1| 国产99久久九九免费精品| 亚洲成av片中文字幕在线观看| 黄色a级毛片大全视频| www.999成人在线观看| av国产精品久久久久影院| 久久久久精品人妻al黑| 99精品在免费线老司机午夜| 国产欧美日韩精品亚洲av| 久久久久久久久免费视频了| 91精品三级在线观看|